Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTB
2376
Connect Biopharma Holdings
CNTB
$124M
| $947K | ﹤0.01% |
+313,732
| New | +$1.32M |
|
2377
BRC Group Holdings
RILY
$301M
| $947K | ﹤0.01% |
13,544
-12,478
| -48% | -$845K |
|
|
RNAM
2378
DELISTED
Avidity Biosciences
RNAM
| $947K | ﹤0.01% |
+51,326
| New | +$872K |
|
2379
CTS Corp
CTS
$1.86B
| $946K | ﹤0.01% |
26,765
-15,889
| -37% | -$555K |
|
|
FSNB
2380
DELISTED
Fusion Acquisition Corp. II
FSNB
| $946K | ﹤0.01% |
+96,564
| New | +$939K |
|
|
SNBR
2381
DELISTED
Sleep Number
SNBR
| $945K | ﹤0.01% |
18,648
-133,797
| -88% | -$9.08M |
|
2382
Bloom Energy
BE
$64.3B
| $941K | ﹤0.01% |
38,982
-420,160
| -92% | -$8.21M |
|
2383
Crane NXT
CXT
$3.09B
| $941K | ﹤0.01% |
25,030
-119,663
| -83% | -$4.31M |
|
2384
PUT
PepsiCo
PEP
$191B
| $938K | ﹤0.01% |
5,600
-57,600
| -91% | -$9.67M |
|
|
PDOT
2385
DELISTED
Peridot Acquisition Corp. II
PDOT
| $938K | ﹤0.01% |
+95,869
| New | +$933K |
|
2386
Shenandoah Telecom
SHEN
$689M
| $935K | ﹤0.01% |
39,686
-23,580
| -37% | -$532K |
|
|
SCLE
2387
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $935K | ﹤0.01% |
+95,050
| New | +$937K |
|
2388
Kelly Services Class A
KELYA
$520M
| $933K | ﹤0.01% |
43,072
-24,361
| -36% | -$474K |
|
2389
Tango Therapeutics
TNGX
$4.43B
| $932K | ﹤0.01% |
+122,909
| New | +$1.07M |
|
|
NLSN
2390
CALL
DELISTED
Nielsen Holdings plc
NLSN
| $932K | ﹤0.01% |
+34,200
| New | +$679K |
|
2391
Advanced Drainage Systems
WMS
$11.1B
| $931K | ﹤0.01% |
7,836
+7,760
| +10,211% | +$921K |
|
2392
MGP Ingredients
MGPI
$370M
| $930K | ﹤0.01% |
10,864
-7,493
| -41% | -$604K |
|
2393
Midland States Bancorp
MSBI
$711M
| $930K | ﹤0.01% |
32,188
-21,193
| -40% | -$606K |
|
2394
Sally Beauty Holdings
SBH
$1.54B
| $930K | ﹤0.01% |
59,604
-77,231
| -56% | -$1.34M |
|
2395
Yelp
YELP
$1.47B
| $928K | ﹤0.01% |
27,254
-79,913
| -75% | -$2.74M |
|
2396
Monarch Casino & Resort
MCRI
$2.24B
| $927K | ﹤0.01% |
10,619
-6,544
| -38% | -$489K |
|
|
ONEM
2397
DELISTED
1Life Healthcare
ONEM
| $925K | ﹤0.01% |
+83,448
| New | +$935K |
|
2398
Veracyte
VCYT
$3.58B
| $924K | ﹤0.01% |
33,491
-60,625
| -64% | -$1.73M |
|
|
CSTR
2399
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $924K | ﹤0.01% |
43,822
-21,527
| -33% | -$460K |
|
2400
Natera
NTRA
$38.7B
| $921K | ﹤0.01% |
22,653
+4,142
| +22% | +$249K |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.